International Journal of Dermatology · 2001 · 29 citations · 26 references
MedicineDermatologyPathologyCutaneous OncologyDermatopathologyImmunopathologyAtopic DermatitisCutaneous LymphomaCutaneous NeoplasmsImmunopathology Of SkinInflammatory DermatosesSkin TumorsAtopic Dermatitis AssociationAtopic Dermatitis ImmunopathologyCutaneous T-cell Lymphoma ImmunopathologyCutaneous T-cell Lymphoma TreatmentLymph Node HistopathologyLymphoma StagingPsoriasiform DermatitisTopical Psoralen Therapy
BACKGROUND: Mycosis fungoides (MF) may evolve from pre-existing chronic atopic or psoriasiform dermatitis and the histology can be equivocal. Early patch and plaque lesions of MF may evolve into tumors, disseminate to lymph nodes, bone marrow, and internal organs, and/or undergo transformation to a large cell size. METHODS: A patient with a history of "atopic dermatitis" followed by "psoriasis" rapidly developed exfoliative erythroderma and axillary lymphadenopathy following treatment with cyclosporine. At presentation, biopsy specimens of skin lesions and lymph nodes and staging were obtained. We present the treatment and follow-up of this patient and review the medical literature for similar cases. RESULTS: Multiple skin biopsy specimens from lesions revealed changes consistent with low-grade, cutaneous, T-cell lymphoma (MF) without evidence of large cell transformation and psoriasiform epidermal hyperplasia. CD30+ large cell transformation was present in the lymph node. Adenopathy and erythroderma resolved without systemic therapy following discontinuation of cyclosporine and treatment with psoralen/ultraviolet A (PUVA), isotretinoin, interferon-alpha, and antimicrobials. CONCLUSIONS: This case documents a close relationship between atopy, psoriasis, and the development of cutaneous T-cell lymphoma, and illustrates that an immunosuppressive agent, cyclosporine, can dramatically alter the course of the disease.
26
Marco Paulli, Emilio Berti, R. Rosso et al. · Journal of Clinical Oncology · 1995 · 253 citations
Medicine, Dermatology, Pathology +17